Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review

Gespeichert in:

Autor*in:	LI Huiting [verfasserIn] CAI Mei [verfasserIn] BI Hui [verfasserIn]

Format:	E-Artikel
Sprache:	Chinesisch

Erschienen:	2022

Übergeordnetes Werk:	In: Zhongliu Fangzhi Yanjiu - Magazine House of Cancer Research on Prevention and Treatment, 2019, 49(2022), 11, Seite 1202-1204
Übergeordnetes Werk:	volume:49 ; year:2022 ; number:11 ; pages:1202-1204

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.3971/j.issn.1000-8578.2022.22.0258

Katalog-ID:	DOAJ085620270

Internformat


LEADER	01000naa a22002652 4500
001	DOAJ085620270
003	DE-627
005	20230311040020.0
007	cr uuu---uuuuu
008	230311s2022 xx \|\|\|\|\|o 00\| \|\|chi c
024	7		\|a 10.3971/j.issn.1000-8578.2022.22.0258 \|2 doi
035			\|a (DE-627)DOAJ085620270
035			\|a (DE-599)DOAJ8790bea963514740b671e729793ebc7b
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a chi
050		0	\|a RC254-282
100	0		\|a LI Huiting \|e verfasserin \|4 aut
245	1	0	\|a Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review
264		1	\|c 2022
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
653		0	\|a Neoplasms. Tumors. Oncology. Including cancer and carcinogens
700	0		\|a CAI Mei \|e verfasserin \|4 aut
700	0		\|a BI Hui \|e verfasserin \|4 aut
773	0	8	\|i In \|t Zhongliu Fangzhi Yanjiu \|d Magazine House of Cancer Research on Prevention and Treatment, 2019 \|g 49(2022), 11, Seite 1202-1204 \|w (DE-627)176063638X \|x 10008578 \|7 nnns
773	1	8	\|g volume:49 \|g year:2022 \|g number:11 \|g pages:1202-1204
856	4	0	\|u https://doi.org/10.3971/j.issn.1000-8578.2022.22.0258 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/8790bea963514740b671e729793ebc7b \|z kostenfrei
856	4	0	\|u http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0258 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1000-8578 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
951			\|a AR
952			\|d 49 \|j 2022 \|e 11 \|h 1202-1204

Indexfelder

author_variant	l h lh c m cm b h bh
matchkey_str	article:10008578:2022----::uaeusumuclcrioauigaaiitetetocrncylilueia
hierarchy_sort_str	2022
callnumber-subject-code	RC
publishDate	2022
allfields	10.3971/j.issn.1000-8578.2022.22.0258 doi (DE-627)DOAJ085620270 (DE-599)DOAJ8790bea963514740b671e729793ebc7b DE-627 ger DE-627 rakwb chi RC254-282 LI Huiting verfasserin aut Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Neoplasms. Tumors. Oncology. Including cancer and carcinogens CAI Mei verfasserin aut BI Hui verfasserin aut In Zhongliu Fangzhi Yanjiu Magazine House of Cancer Research on Prevention and Treatment, 2019 49(2022), 11, Seite 1202-1204 (DE-627)176063638X 10008578 nnns volume:49 year:2022 number:11 pages:1202-1204 https://doi.org/10.3971/j.issn.1000-8578.2022.22.0258 kostenfrei https://doaj.org/article/8790bea963514740b671e729793ebc7b kostenfrei http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0258 kostenfrei https://doaj.org/toc/1000-8578 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 49 2022 11 1202-1204
spelling	10.3971/j.issn.1000-8578.2022.22.0258 doi (DE-627)DOAJ085620270 (DE-599)DOAJ8790bea963514740b671e729793ebc7b DE-627 ger DE-627 rakwb chi RC254-282 LI Huiting verfasserin aut Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Neoplasms. Tumors. Oncology. Including cancer and carcinogens CAI Mei verfasserin aut BI Hui verfasserin aut In Zhongliu Fangzhi Yanjiu Magazine House of Cancer Research on Prevention and Treatment, 2019 49(2022), 11, Seite 1202-1204 (DE-627)176063638X 10008578 nnns volume:49 year:2022 number:11 pages:1202-1204 https://doi.org/10.3971/j.issn.1000-8578.2022.22.0258 kostenfrei https://doaj.org/article/8790bea963514740b671e729793ebc7b kostenfrei http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0258 kostenfrei https://doaj.org/toc/1000-8578 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 49 2022 11 1202-1204
allfields_unstemmed	10.3971/j.issn.1000-8578.2022.22.0258 doi (DE-627)DOAJ085620270 (DE-599)DOAJ8790bea963514740b671e729793ebc7b DE-627 ger DE-627 rakwb chi RC254-282 LI Huiting verfasserin aut Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Neoplasms. Tumors. Oncology. Including cancer and carcinogens CAI Mei verfasserin aut BI Hui verfasserin aut In Zhongliu Fangzhi Yanjiu Magazine House of Cancer Research on Prevention and Treatment, 2019 49(2022), 11, Seite 1202-1204 (DE-627)176063638X 10008578 nnns volume:49 year:2022 number:11 pages:1202-1204 https://doi.org/10.3971/j.issn.1000-8578.2022.22.0258 kostenfrei https://doaj.org/article/8790bea963514740b671e729793ebc7b kostenfrei http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0258 kostenfrei https://doaj.org/toc/1000-8578 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 49 2022 11 1202-1204
allfieldsGer	10.3971/j.issn.1000-8578.2022.22.0258 doi (DE-627)DOAJ085620270 (DE-599)DOAJ8790bea963514740b671e729793ebc7b DE-627 ger DE-627 rakwb chi RC254-282 LI Huiting verfasserin aut Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Neoplasms. Tumors. Oncology. Including cancer and carcinogens CAI Mei verfasserin aut BI Hui verfasserin aut In Zhongliu Fangzhi Yanjiu Magazine House of Cancer Research on Prevention and Treatment, 2019 49(2022), 11, Seite 1202-1204 (DE-627)176063638X 10008578 nnns volume:49 year:2022 number:11 pages:1202-1204 https://doi.org/10.3971/j.issn.1000-8578.2022.22.0258 kostenfrei https://doaj.org/article/8790bea963514740b671e729793ebc7b kostenfrei http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0258 kostenfrei https://doaj.org/toc/1000-8578 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 49 2022 11 1202-1204
allfieldsSound	10.3971/j.issn.1000-8578.2022.22.0258 doi (DE-627)DOAJ085620270 (DE-599)DOAJ8790bea963514740b671e729793ebc7b DE-627 ger DE-627 rakwb chi RC254-282 LI Huiting verfasserin aut Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Neoplasms. Tumors. Oncology. Including cancer and carcinogens CAI Mei verfasserin aut BI Hui verfasserin aut In Zhongliu Fangzhi Yanjiu Magazine House of Cancer Research on Prevention and Treatment, 2019 49(2022), 11, Seite 1202-1204 (DE-627)176063638X 10008578 nnns volume:49 year:2022 number:11 pages:1202-1204 https://doi.org/10.3971/j.issn.1000-8578.2022.22.0258 kostenfrei https://doaj.org/article/8790bea963514740b671e729793ebc7b kostenfrei http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0258 kostenfrei https://doaj.org/toc/1000-8578 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 49 2022 11 1202-1204
language	Chinese
source	In Zhongliu Fangzhi Yanjiu 49(2022), 11, Seite 1202-1204 volume:49 year:2022 number:11 pages:1202-1204
sourceStr	In Zhongliu Fangzhi Yanjiu 49(2022), 11, Seite 1202-1204 volume:49 year:2022 number:11 pages:1202-1204
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Neoplasms. Tumors. Oncology. Including cancer and carcinogens
isfreeaccess_bool	true
container_title	Zhongliu Fangzhi Yanjiu
authorswithroles_txt_mv	LI Huiting @@aut@@ CAI Mei @@aut@@ BI Hui @@aut@@
publishDateDaySort_date	2022-01-01T00:00:00Z
hierarchy_top_id	176063638X
id	DOAJ085620270
language_de	chinesisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ085620270</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230311040020.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2022 xx \|\|\|\|\|o 00\| \|\|chi c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3971/j.issn.1000-8578.2022.22.0258</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ085620270</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ8790bea963514740b671e729793ebc7b</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">chi</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">LI Huiting</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">CAI Mei</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">BI Hui</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Zhongliu Fangzhi Yanjiu</subfield><subfield code="d">Magazine House of Cancer Research on Prevention and Treatment, 2019</subfield><subfield code="g">49(2022), 11, Seite 1202-1204</subfield><subfield code="w">(DE-627)176063638X</subfield><subfield code="x">10008578</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:49</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:1202-1204</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3971/j.issn.1000-8578.2022.22.0258</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/8790bea963514740b671e729793ebc7b</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0258</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1000-8578</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">49</subfield><subfield code="j">2022</subfield><subfield code="e">11</subfield><subfield code="h">1202-1204</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	LI Huiting
spellingShingle	LI Huiting misc RC254-282 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review
authorStr	LI Huiting
ppnlink_with_tag_str_mv	@@773@@(DE-627)176063638X
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC254-282
illustrated	Not Illustrated
issn	10008578
topic_title	RC254-282 Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review
topic	misc RC254-282 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_unstemmed	misc RC254-282 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_browse	misc RC254-282 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Zhongliu Fangzhi Yanjiu
hierarchy_parent_id	176063638X
hierarchy_top_title	Zhongliu Fangzhi Yanjiu
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)176063638X
title	Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review
ctrlnum	(DE-627)DOAJ085620270 (DE-599)DOAJ8790bea963514740b671e729793ebc7b
title_full	Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review
author_sort	LI Huiting
journal	Zhongliu Fangzhi Yanjiu
journalStr	Zhongliu Fangzhi Yanjiu
callnumber-first-code	R
lang_code	chi
isOA_bool	true
recordtype	marc
publishDateSort	2022
contenttype_str_mv	txt
container_start_page	1202
author_browse	LI Huiting CAI Mei BI Hui
container_volume	49
class	RC254-282
format_se	Elektronische Aufsätze
author-letter	LI Huiting
doi_str_mv	10.3971/j.issn.1000-8578.2022.22.0258
author2-role	verfasserin
title_sort	cutaneous squamous-cell carcinoma during dasatinib treatment for chronic myeloid leukemia: a case report and literature review
callnumber	RC254-282
title_auth	Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ
container_issue	11
title_short	Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review
url	https://doi.org/10.3971/j.issn.1000-8578.2022.22.0258 https://doaj.org/article/8790bea963514740b671e729793ebc7b http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0258 https://doaj.org/toc/1000-8578
remote_bool	true
author2	CAI Mei BI Hui
author2Str	CAI Mei BI Hui
ppnlink	176063638X
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.3971/j.issn.1000-8578.2022.22.0258
callnumber-a	RC254-282
up_date	2024-07-03T15:52:20.002Z
_version_	1803573725764780032
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ085620270</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230311040020.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2022 xx \|\|\|\|\|o 00\| \|\|chi c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3971/j.issn.1000-8578.2022.22.0258</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ085620270</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ8790bea963514740b671e729793ebc7b</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">chi</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">LI Huiting</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">CAI Mei</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">BI Hui</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Zhongliu Fangzhi Yanjiu</subfield><subfield code="d">Magazine House of Cancer Research on Prevention and Treatment, 2019</subfield><subfield code="g">49(2022), 11, Seite 1202-1204</subfield><subfield code="w">(DE-627)176063638X</subfield><subfield code="x">10008578</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:49</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:1202-1204</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3971/j.issn.1000-8578.2022.22.0258</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/8790bea963514740b671e729793ebc7b</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0258</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1000-8578</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">49</subfield><subfield code="j">2022</subfield><subfield code="e">11</subfield><subfield code="h">1202-1204</subfield></datafield></record></collection>
score	7.4013987

Nicht das Richtige dabei?

Schreiben Sie uns!

Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?